| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/26/2005 | EP1499336A2 Protease inhibitors |
| 01/26/2005 | EP1499327A2 Beta -amyloid peptide-binding proteins and polynucleotides encoding the same |
| 01/26/2005 | EP1499324A1 Method for treating and preventing hyperparathyroidism |
| 01/26/2005 | EP1499321A2 Methods for increasing the therapeutic response to electroconvulsive therapy ("ect") |
| 01/26/2005 | EP1499320A1 Novel compounds |
| 01/26/2005 | EP1499315A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia |
| 01/26/2005 | EP1499314A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 01/26/2005 | EP1499311A1 Substituted benzazoles and use thereof as raf kinase inhibitors |
| 01/26/2005 | EP1499309A1 Prevention and treatment of functional somatic disorders, including stress-related disorders |
| 01/26/2005 | EP1499308A2 Tri-substituted heteroaryls and methods of making and using the same |
| 01/26/2005 | EP1499306A2 Bicyclic amides |
| 01/26/2005 | EP1499305A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 01/26/2005 | EP1499297A2 Pharmaceutical formulation comprising atorvastatin calcium |
| 01/26/2005 | EP1499284A1 Biologically active compounds for the modification of bodily odours |
| 01/26/2005 | EP1499277A2 Modification of feeding behavior |
| 01/26/2005 | EP1499204A2 Physiologically compatible, phospholipid-containing, stable and hard matrix |
| 01/26/2005 | EP1499190A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b |
| 01/26/2005 | EP1499184A2 Methods and compositions for treating ectoparasite infestation |
| 01/26/2005 | EP1427727B1 Compounds which inhibit the release of inflammatory cytokines |
| 01/26/2005 | EP1379522B1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I |
| 01/26/2005 | EP1330237B1 Delivery system for entrapping charged macromolecules and a method for preparing same |
| 01/26/2005 | EP1301514B1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/26/2005 | EP1278749B1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/26/2005 | EP1239867B1 Methods for treating and preventing damage to mucosal tissue |
| 01/26/2005 | EP1203233B1 Method for identifying modulating compounds of neurotransmitters |
| 01/26/2005 | EP1152009B1 Novel nucleosides and oligonucleotide analogues |
| 01/26/2005 | EP1131062B1 Injectable propofol formulations |
| 01/26/2005 | EP1120409B1 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 01/26/2005 | EP1117409B1 Benzenesulfonyl(thio)ureas in combination with beta-blockers for the treatment of dysfunctions of the autonomous nervous system |
| 01/26/2005 | EP1082303B1 Heterocyclic derivatives which inhibit factor xa |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | EP0934412B1 HUMAN THYMOSIN beta 15 GENE, PROTEIN AND USES THEREOF |
| 01/26/2005 | EP0866691B2 Sublingual and buccal administration of selegiline |
| 01/26/2005 | EP0844877B1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 01/26/2005 | EP0725826B1 Improvements relating to cancer therapy |
| 01/26/2005 | EP0652953B1 Morphogenic protein soluble complex and composition thereof |
| 01/26/2005 | CN1571793A Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571789A Himbacine analogues as thrombin receptor antagonists |
| 01/26/2005 | CN1571786A Alkyl ether derivatives or salts thereof |
| 01/26/2005 | CN1571782A Piperidine- and piperazineacetamines as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/26/2005 | CN1571781A 4-imidazolin-2-one compounds |
| 01/26/2005 | CN1571774A Pyrimidinones as melanin concentrating hormone receptor 1 |
| 01/26/2005 | CN1571766A Novel compounds, their preparation and use |
| 01/26/2005 | CN1571676A Biphasic mixtures of GLP-1 and insulin |
| 01/26/2005 | CN1571672A Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes, and vascular and renal disorders |
| 01/26/2005 | CN1571671A Drugs comprising combination of triazaspiro [5.5] undecane derivative with cytochrome p450 isozyme 3A4 inhibitor and/or P-glycoprotein inhibitor |
| 01/26/2005 | CN1571670A Treating sexual desire disorders with flibanserin |
| 01/26/2005 | CN1571669A Novel combination |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1571665A Substituted N-phenyl 2-hydroxy-2-methyl-3, 3, 3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 01/26/2005 | CN1570077A Grifola frondosa mycelia moisture method ultramicro wall break method |
| 01/26/2005 | CN1569883A Pineapple anhydride compound and its use |
| 01/26/2005 | CN1569869A Chinese chestnut flower flavone compounds |
| 01/26/2005 | CN1569868A Pineapple flavonoid glycoside compound and its use |
| 01/26/2005 | CN1569207A Prescription for blackening hair and prolonging life and its preparation |
| 01/26/2005 | CN1569196A Rhodiola sacra injection and its preparation |
| 01/26/2005 | CN1569195A Rhodiola sacra soft capsule and its preparation |
| 01/26/2005 | CN1569181A Chinese medicine for preventing and treating air pollution harm and its preparation method |
| 01/26/2005 | CN1569155A Chinese traditional medicine for treating appendicitis |
| 01/26/2005 | CN1569107A Medicine for treating female chronic fatigue syndrome and its preparing process |
| 01/26/2005 | CN1569093A Biological agent for refreshing head and resisting fatigue |
| 01/26/2005 | CN1569069A Medicine with functions of nourishing qi, consolidate superficial resistance and suppressing sweating |
| 01/26/2005 | CN1569055A Chinese traditional medicine for treating Tourette |
| 01/26/2005 | CN1569031A Plasma component series preparation by inactivating virus and sieving sectionally by hyperfiltration membrane |
| 01/26/2005 | CN1569023A Chitosan chewing tablet and its preparation method |
| 01/26/2005 | CN1569017A Total epimeddium flavone tablet and its preparation method |
| 01/26/2005 | CN1568973A Composition of vitamin C and arginine and its application |
| 01/26/2005 | CN1186353C 17 peptide organic compound and its application |
| 01/26/2005 | CN1186344C Amino acid compounds and use thereof as NEP, ACE and ECE inhibitors |
| 01/26/2005 | CN1186328C Substd. 5-benzyl-2, 4-diaminopyrimidines |
| 01/26/2005 | CN1186324C Condensed heteroaryl derivatives |
| 01/26/2005 | CN1186322C Proline derivatives and use thereof as drugs |
| 01/26/2005 | CN1186315C O-anisamide derivatives |
| 01/26/2005 | CN1186094C Piracetam medicine composition with function of promoting thinking and memory and its preparation |
| 01/26/2005 | CN1186085C Traditional Chinese medicine for treating deformed soft-tissue |
| 01/26/2005 | CN1186067C Medicine for treating acute muscle and tendon injury and its preparation method |
| 01/26/2005 | CN1186046C Ointment for treating gynecopathy and its preparing method |
| 01/26/2005 | CN1186032C Health-care food prepared from extracts of animals bone marrow and Chinese-medicinal materials |
| 01/26/2005 | CN1186020C Acylbenzoxazine for enhancing synaptic response(s) |
| 01/26/2005 | CN1186014C Multi-particulate pharmaceutical form with programmed and timed releasing and preparation method thereof |
| 01/25/2005 | US6846931 Organic acid salt of amlodipine |
| 01/25/2005 | US6846920 Comprises nucleotide sequences coding eosinophil protease (EOS) for preparing laundry detergents, stain-removing solutions, skin care products and treating blood and respiratory system disorders |
| 01/25/2005 | US6846907 Osteoporosis treatment |
| 01/25/2005 | US6846906 Modified proteins of the TGF-β superfamily, including morphogenic proteins |
| 01/25/2005 | US6846844 (3R)-5-((2-hydroxy-4-methylphenyl)amino)-3-methyl-5-oxo-pentan oic acid, or 3,5-dichloro derivative or salts thereof; deliver active agents to selected biological systems in increased or improved bioavailability |
| 01/25/2005 | US6846835 Treating chronic obstructive pulmonary disease, chronic bronchitis, asthma, chronic respiratory tract obstruction, fibroid lung, pulmonary emphysema or rhinitis |
| 01/25/2005 | US6846834 Antiinflammation agents |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/25/2005 | US6846832 Highly selective monoamine oxidase B inhibitors; treating Alzheimer's disease, Parkinson's disease, and senile dementia |
| 01/25/2005 | US6846830 Naphtalene derivatives and their pharmaceutical use |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846828 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/25/2005 | US6846822 Product comprising a heterotrimeric G protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension |
| 01/25/2005 | US6846821 Tetrahydrothiopy ranphthalazinone derivatives as PDE4 inhibitors |
| 01/25/2005 | US6846819 Bactericides compound containing acrylamide group |
| 01/25/2005 | US6846818 Selective inhibitors of cyclooxygenase-2 |
| 01/25/2005 | US6846816 Combinations of drugs for the treatment of neoplastic disorders |
| 01/25/2005 | US6846815 Heterocyclic imines such as 2-anilino-6-quinoxalinol, used to suppress cell proliferation, differentiation, chemotaxis and/or activation; prophylaxis of restinosis; anticarcinogenic agents |